Clinical Trial Update: Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Pfizer's AN2728 (crisaborole) topical ointment was studied in adolescents with atopic dermatitis in a Phase 2 trial to assess efficacy and safety; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AN2728 (crisaborole) (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06